Global report recommends hearTest App for hearing assessment in TB patients

February 21, 2018

Search for articles by category

The guideline report addresses the fact that quality of life in people with drug-resistant tuberculosis (DR-TB) can be badly affected by adverse drug reactions and that the second-line anti-TB injectables (SLIs), which are an essential class of agents in the treatment of DR-TB, are known to cause adverse reactions that may have lasting effects such as hearing loss.

Hearing loss has a potential impact on children’s learning and development, and, among adults, it has an impact on employment, education, and general well-being. It is therefore important to diagnose hearing loss as early as possible. The report is intended to help health providers use audiometry to make informed and patient-centered decisions to prevent and manage ototoxicity resulting from SLIs.

Ototoxicity refers to the damage to the auditory cranial nerve causing irreversible symptoms, such as hearing loss, tinnitus (ringing of the ear), and/or other vestibular symptoms such as nystagmus, ataxia, and disequilibrium.

The document recommends audiometry as a baseline test for all patients starting DR-TB treatment, and as a follow-up test while on the SLI. The early detection of hearing loss is recommended as an aid to decision-making regarding the use of SLI in the management of DR-TB.

In consideration of the fact that most persons undergoing treatment for DR-TB reside in low-resource settings with lack of technical resources and personnel, the report recommends monthly hearing screening using audiometers which have the following desired features:

  • Good sound management, which eliminates the need for a sound booth to do audiometry testing, and allows the test to be done in normal environments
  • Dual power supply from alternating current (A/C) and a battery, as this solves the problem of interrupted electricity in the field, or having to find a power source for cord connection
  • Connectivity to a computer - models with web-based computer connectivity generate electronic recording of audiogram files that can be printed, stored on memory and organised into patient folders
  • Patient-friendly procedure
  • Calibration
  • Minimal training required for health staff doing the hearing tests, and availability of technical support
  • Minimal need for specialist interpretation
  • Warranties and affordability

The hearTest app goes above and beyond the above features offering reliable, clinically-validated and cost-effective audiometry on a smartphone with integrated cloud-based data management.


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.